CEACAM5 and gastric cancer: We discovered that tRF-23-Q99P9P9NDD expression was considerably higher in GC patients with CEA ≥ 5 ng/mL than in patients with CEA < 5 ng/mL (P < 0.0001) (Fig. 4A).